Simone Mirabilii

Pubblicazioni

Titolo Pubblicato in Anno
Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition CURRENT ISSUES IN MOLECULAR BIOLOGY 2024
Doxorubicin-Induced Cardiac Senescence Is Alleviated Following Treatment with Combined Polyphenols and Micronutrients through Enhancement in Mitophagy CELLS 2023
Sirt5 inhibition induces brown fat-like phenotype in 3t3-l1 preadipocytes CELLS 2021
Corrigendum: Metabolic Reprogramming Promotes Myogenesis During Aging (Front. Physiol., (2019), 10, (897), 10.3389/fphys.2019.00897) FRONTIERS IN PHYSIOLOGY 2021
mTOR regulation of metabolism in hematologic malignancies CELLS 2020
A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia. case report and literature review BMC CANCER 2019
Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation BONE MARROW TRANSPLANTATION 2019
Metabolic reprogramming promotes myogenesis during aging FRONTIERS IN PHYSIOLOGY 2019
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients ONCOTARGET 2018
Biological aspects of mTOR in leukemia INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2018
Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia ADVANCES IN BIOLOGICAL REGULATION 2017
Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin SCIENTIFIC REPORTS 2017
Tramesan, a novel polysaccharide from trametes versicolor. structural characterization and biological effects PLOS ONE 2017
Preclinical antileukemia activity of tramesan. A newly identified bioactive fungal metabolite OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2017
Erratum: The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia SCIENTIFIC REPORTS 2016
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia ONCOTARGET 2015
Targeting the leukemia cell metabolism by the CPT1a inhibition. functional pre-clinical effects in leukemias BLOOD 2015
The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia HAEMATOLOGICA 2015
The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia SCIENTIFIC REPORTS 2015

ERC

  • LS1_7
  • LS1_9
  • LS1_13
  • LS3_1
  • LS3_5
  • LS4_11
  • LS4_12

KET

  • Life-science technologies & biotechnologies

Keywords

cancer metabolism
Acute leukemia
cell signaling
cancer resistance
translational medicine
metabolic profiling
Targeted therapy

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma